ELISE KACAN: Open Payments
NPI 1093434367 · LAKEWAY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$472 in 18 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $72 · 2025 $472
Food & beverage: $472
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $159 |
| Antares Pharma, Inc. | 1 | $116 |
| Lilly USA, LLC | 3 | $56 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $49 |
| Dexcom, Inc. | 2 | $41 |
| ABBVIE INC. | 1 | $19 |
| Collegium Pharmaceutical, Inc. | 1 | $16 |
| Merck Sharp & Dohme LLC | 1 | $15 |
Products named: XYOSTED, MOUNJARO, Ozempic, JARDIANCE, Dexcom G6 Transmitter, Rybelsus, Wegovy, VRAYLAR.
Industry payments across TX — which companies pay providers there.
